This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Münger, K
Right arrow Articles by Schlegel, R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Münger, K
Right arrow Articles by Schlegel, R

 Previous Article  |  Next Article 

J Virol. 1989 October; 63(10): 4417-4421

The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

K Münger, W C Phelps, V Bubb, P M Howley and R Schlegel

Laboratory of Tumor Virus Biology, National Cancer Institute, Bethesda, Maryland 20892.

ABSTRACT

The early human papillomavirus type 16 genes that directly participate in the in vitro transformation of primary human keratinocytes have been defined. In the context of the full viral genome, mutations in either the E6 or E7 open reading frame completely abrogated transformation of these cells. Mutations in the E1, E2, and E2-E4 open reading frames, on the other hand, had no effect. Thus, both the full-length E6 and E7 genes were required for the induction of keratinocyte immortalization and resistance to terminal differentiation. The E6 and E7 genes expressed together from the human beta-actin promoter were sufficient for this transformation; mutation of either gene in the context of this recombinant plasmid eliminated the ability to induce stable differentiation-resistant transformants.

J Virol. 1989 October; 63(10): 4417-4421




This article has been cited by other articles:

  • Boulet, G. A.V., Benoy, I. H., Depuydt, C. E., Horvath, C. A.J., Aerts, M., Hens, N., Vereecken, A. J., Bogers, J. J. (2009). Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia >=2 in a Liquid-Based Cytology Setting?. Cancer Epidemiol. Biomarkers Prev. 18: 2992-2999 [Abstract] [Full Text]  
  • Shin, M.-K., Balsitis, S., Brake, T., Lambert, P. F. (2009). Human Papillomavirus E7 Oncoprotein Overrides the Tumor Suppressor Activity of p21Cip1 in Cervical Carcinogenesis. Cancer Res. 69: 5656-5663 [Abstract] [Full Text]  
  • Jabbar, S. F., Abrams, L., Glick, A., Lambert, P. F. (2009). Persistence of High-Grade Cervical Dysplasia and Cervical Cancer Requires the Continuous Expression of the Human Papillomavirus Type 16 E7 Oncogene. Cancer Res. 69: 4407-4414 [Abstract] [Full Text]  
  • Nobre, R. J., Herraez-Hernandez, E., Fei, J.-W., Langbein, L., Kaden, S., Grone, H.-J., de Villiers, E.-M. (2009). E7 Oncoprotein of Novel Human Papillomavirus Type 108 Lacking the E6 Gene Induces Dysplasia in Organotypic Keratinocyte Cultures. J. Virol. 83: 2907-2916 [Abstract] [Full Text]  
  • Bousarghin, L., Touze, A., Gaud, G., Iochmann, S., Alvarez, E., Reverdiau, P., Gaitan, J., Jourdan, M.-L., Sizaret, P.-Y., Coursaget, P. L. (2009). Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs. Molecular Cancer Therapeutics 8: 357-365 [Abstract] [Full Text]  
  • Chung, S.-H., Wiedmeyer, K., Shai, A., Korach, K. S., Lambert, P. F. (2008). Requirement for Estrogen Receptor {alpha} in a Mouse Model for Human Papillomavirus-Associated Cervical Cancer. Cancer Res. 68: 9928-9934 [Abstract] [Full Text]  
  • Spardy, N., Duensing, A., Hoskins, E. E., Wells, S. I., Duensing, S. (2008). HPV-16 E7 Reveals a Link between DNA Replication Stress, Fanconi Anemia D2 Protein, and Alternative Lengthening of Telomere-Associated Promyelocytic Leukemia Bodies. Cancer Res. 68: 9954-9963 [Abstract] [Full Text]  
  • Liu, X., Dakic, A., Chen, R., Disbrow, G. L., Zhang, Y., Dai, Y., Schlegel, R. (2008). Cell-Restricted Immortalization by Human Papillomavirus Correlates with Telomerase Activation and Engagement of the hTERT Promoter by Myc. J. Virol. 82: 11568-11576 [Abstract] [Full Text]  
  • Nguyen, C. L., McLaughlin-Drubin, M. E., Munger, K. (2008). Delocalization of the Microtubule Motor Dynein from Mitotic Spindles by the Human Papillomavirus E7 Oncoprotein Is Not Sufficient for Induction of Multipolar Mitoses. Cancer Res. 68: 8715-8722 [Abstract] [Full Text]  
  • Underbrink, M. P., Howie, H. L., Bedard, K. M., Koop, J. I., Galloway, D. A. (2008). E6 Proteins from Multiple Human Betapapillomavirus Types Degrade Bak and Protect Keratinocytes from Apoptosis after UVB Irradiation. J. Virol. 82: 10408-10417 [Abstract] [Full Text]  
  • McLaughlin-Drubin, M. E., Huh, K.-W., Munger, K. (2008). Human Papillomavirus Type 16 E7 Oncoprotein Associates with E2F6. J. Virol. 82: 8695-8705 [Abstract] [Full Text]  
  • Shai, A., Pitot, H. C., Lambert, P. F. (2008). p53 Loss Synergizes with Estrogen and Papillomaviral Oncogenes to Induce Cervical and Breast Cancers. Cancer Res. 68: 2622-2631 [Abstract] [Full Text]  
  • Bedard, K. M., Underbrink, M. P., Howie, H. L., Galloway, D. A. (2008). The E6 Oncoproteins from Human Betapapillomaviruses Differentially Activate Telomerase through an E6AP-Dependent Mechanism and Prolong the Lifespan of Primary Keratinocytes. J. Virol. 82: 3894-3902 [Abstract] [Full Text]  
  • Ressler, S., Scheiden, R., Dreier, K., Laich, A., Muller-Holzner, E., Pircher, H., Morandell, D., Stein, I., Viertler, H.-P., Santer, F. R., Widschwendter, A., Even, J., Jansen-Durr, P., Capesius, C., Zwerschke, W. (2007). High-risk Human Papillomavirus E7 Oncoprotein Detection in Cervical Squamous Cell Carcinoma. Clin. Cancer Res. 13: 7067-7072 [Abstract] [Full Text]  
  • Liu, X., Disbrow, G. L., Yuan, H., Tomaic, V., Schlegel, R. (2007). Myc and Human Papillomavirus Type 16 E7 Genes Cooperate To Immortalize Human Keratinocytes. J. Virol. 81: 12689-12695 [Abstract] [Full Text]  
  • Berraondo, P., Nouze, C., Preville, X., Ladant, D., Leclerc, C. (2007). Eradication of Large Tumors in Mice by a Tritherapy Targeting the Innate, Adaptive, and Regulatory Components of the Immune System. Cancer Res. 67: 8847-8855 [Abstract] [Full Text]  
  • Maufort, J. P., Genther Williams, S. M., Pitot, H. C., Lambert, P. F. (2007). Human Papillomavirus 16 E5 Oncogene Contributes to Two Stages of Skin Carcinogenesis. Cancer Res. 67: 6106-6112 [Abstract] [Full Text]  
  • Courtete, J., Sibler, A.-P., Zeder-Lutz, G., Dalkara, D., Oulad-Abdelghani, M., Zuber, G., Weiss, E. (2007). Suppression of cervical carcinoma cell growth by intracytoplasmic codelivery of anti-oncoprotein E6 antibody and small interfering RNA. Molecular Cancer Therapeutics 6: 1728-1735 [Abstract] [Full Text]  
  • Subbaramaiah, K., Dannenberg, A. J. (2007). Cyclooxygenase-2 Transcription Is Regulated by Human Papillomavirus 16 E6 and E7 Oncoproteins: Evidence of a Corepressor/Coactivator Exchange. Cancer Res. 67: 3976-3985 [Abstract] [Full Text]  
  • Storrs, C. H., Silverstein, S. J. (2007). PATJ, a Tight Junction-Associated PDZ Protein, Is a Novel Degradation Target of High-Risk Human Papillomavirus E6 and the Alternatively Spliced Isoform 18 E6. J. Virol. 81: 4080-4090 [Abstract] [Full Text]  
  • Bae, S. H., Park, Y.-J., Park, J.-B., Choi, Y. S., Kim, M. S., Sin, J.-I. (2007). Therapeutic Synergy of Human Papillomavirus E7 Subunit Vaccines plus Cisplatin in an Animal Tumor Model: Causal Involvement of Increased Sensitivity of Cisplatin-Treated Tumors to CTL-Mediated Killing in Therapeutic Synergy. Clin. Cancer Res. 13: 341-349 [Abstract] [Full Text]  
  • Peck, R. B., Schweizer, J., Weigl, B. H., Somoza, C., Silver, J., Sellors, J. W., Lu, P. S. (2006). A magnetic immunochromatographic strip test for detection of human papillomavirus 16 E6.. Clin. Chem. 52: 2170-2172 [Full Text]  
  • Hiller, T., Poppelreuther, S., Stubenrauch, F., Iftner, T. (2006). Comparative Analysis of 19 Genital Human Papillomavirus Types with Regard to p53 Degradation, Immortalization, Phylogeny, and Epidemiologic Risk Classification.. Cancer Epidemiol. Biomarkers Prev. 15: 1262-1267 [Abstract] [Full Text]  
  • Banerjee, N. S., Genovese, N. J., Noya, F., Chien, W.-M., Broker, T. R., Chow, L. T. (2006). Conditionally activated e7 proteins of high-risk and low-risk human papillomaviruses induce s phase in postmitotic, differentiated human keratinocytes.. J. Virol. 80: 6517-6524 [Abstract] [Full Text]  
  • Baldwin, A., Huh, K.-W., Munger, K. (2006). Human papillomavirus e7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function.. J. Virol. 80: 6669-6677 [Abstract] [Full Text]  
  • Parish, J. L., Kowalczyk, A., Chen, H.-T., Roeder, G. E., Sessions, R., Buckle, M., Gaston, K. (2006). E2 Proteins from High- and Low-Risk Human Papillomavirus Types Differ in Their Ability To Bind p53 and Induce Apoptotic Cell Death. J. Virol. 80: 4580-4590 [Abstract] [Full Text]  
  • Kraus, I., Molden, T., Holm, R., Lie, A. K., Karlsen, F., Kristensen, G. B., Skomedal, H. (2006). Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical Carcinomas. J. Clin. Microbiol. 44: 1310-1317 [Abstract] [Full Text]  
  • Iuchi, S., Dabelsteen, S., Easley, K., Rheinwald, J. G., Green, H. (2006). Immortalized keratinocyte lines derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 103: 1792-1797 [Abstract] [Full Text]  
  • Liu, X., Clements, A., Zhao, K., Marmorstein, R. (2006). Structure of the Human Papillomavirus E7 Oncoprotein and Its Mechanism for Inactivation of the Retinoblastoma Tumor Suppressor. J. Biol. Chem. 281: 578-586 [Abstract] [Full Text]  
  • Fiedler, M., Ressler, S., Campo-Fernandez, B., Laich, A., Jansen, L., Widschwendter, A., Viertler, H.-P., Bacher, N., Morandell, D., Muller-Holzner, E., Durst, M., Jansen-Durr, P., Zwerschke, W. (2005). Expression of the high-risk human papillomavirus type 18 and 45 E7 oncoproteins in cervical carcinoma biopsies. J. Gen. Virol. 86: 3235-3241 [Abstract] [Full Text]  
  • Collins, A. S., Nakahara, T., Do, A., Lambert, P. F. (2005). Interactions with Pocket Proteins Contribute to the Role of Human Papillomavirus Type 16 E7 in the Papillomavirus Life Cycle. J. Virol. 79: 14769-14780 [Abstract] [Full Text]  
  • Wise-Draper, T. M., Allen, H. V., Thobe, M. N., Jones, E. E., Habash, K. B., Munger, K., Wells, S. I. (2005). The Human DEK Proto-Oncogene Is a Senescence Inhibitor and an Upregulated Target of High-Risk Human Papillomavirus E7. J. Virol. 79: 14309-14317 [Abstract] [Full Text]  
  • Simonson, S. J.S., Difilippantonio, M. J., Lambert, P. F. (2005). Two Distinct Activities Contribute to Human Papillomavirus 16 E6's Oncogenic Potential. Cancer Res. 65: 8266-8273 [Abstract] [Full Text]  
  • Balsitis, S., Dick, F., Lee, D., Farrell, L., Hyde, R. K., Griep, A. E., Dyson, N., Lambert, P. F. (2005). Examination of the pRb-Dependent and pRb-Independent Functions of E7 In Vivo. J. Virol. 79: 11392-11402 [Abstract] [Full Text]  
  • Genther Williams, S. M., Disbrow, G. L., Schlegel, R., Lee, D., Threadgill, D. W., Lambert, P. F. (2005). Requirement of Epidermal Growth Factor Receptor for Hyperplasia Induced by E5, a High-Risk Human Papillomavirus Oncogene. Cancer Res. 65: 6534-6542 [Abstract] [Full Text]  
  • Liu, X., Yuan, H., Fu, B., Disbrow, G. L., Apolinario, T., Tomaic, V., Kelley, M. L., Baker, C. C., Huibregtse, J., Schlegel, R. (2005). The E6AP Ubiquitin Ligase Is Required for Transactivation of the hTERT Promoter by the Human Papillomavirus E6 Oncoprotein. J. Biol. Chem. 280: 10807-10816 [Abstract] [Full Text]  
  • Kelley, M. L., Keiger, K. E., Lee, C. J., Huibregtse, J. M. (2005). The Global Transcriptional Effects of the Human Papillomavirus E6 Protein in Cervical Carcinoma Cell Lines Are Mediated by the E6AP Ubiquitin Ligase. J. Virol. 79: 3737-3747 [Abstract] [Full Text]  
  • Akgul, B., Garcia-Escudero, R., Ghali, L., Pfister, H. J., Fuchs, P. G., Navsaria, H., Storey, A. (2005). The E7 Protein of Cutaneous Human Papillomavirus Type 8 Causes Invasion of Human Keratinocytes into the Dermis in Organotypic Cultures of Skin. Cancer Res. 65: 2216-2223 [Abstract] [Full Text]  
  • Molden, T., Kraus, I., Karlsen, F., Skomedal, H., Nygard, J. F., Hagmar, B. (2005). Comparison of Human Papillomavirus Messenger RNA and DNA Detection: A Cross-sectional Study of 4,136 Women >30 Years of Age with a 2-Year Follow-up of High-Grade Squamous Intraepithelial Lesion. Cancer Epidemiol. Biomarkers Prev. 14: 367-372 [Abstract] [Full Text]  
  • Bischof, O., Nacerddine, K., Dejean, A. (2005). Human Papillomavirus Oncoprotein E7 Targets the Promyelocytic Leukemia Protein and Circumvents Cellular Senescence via the Rb and p53 Tumor Suppressor Pathways. Mol. Cell. Biol. 25: 1013-1024 [Abstract] [Full Text]  
  • Tugizov, S., Berline, J., Herrera, R., Penaranda, M. E., Nakagawa, M., Palefsky, J. (2005). Inhibition of Human Papillomavirus Type 16 E7 Phosphorylation by the S100 MRP-8/14 Protein Complex. J. Virol. 79: 1099-1112 [Abstract] [Full Text]  
  • Routes, J. M., Morris, K., Ellison, M. C., Ryan, S. (2005). Macrophages Kill Human Papillomavirus Type 16 E6-Expressing Tumor Cells by Tumor Necrosis Factor Alpha- and Nitric Oxide-Dependent Mechanisms. J. Virol. 79: 116-123 [Abstract] [Full Text]  
  • Munger, K., Baldwin, A., Edwards, K. M., Hayakawa, H., Nguyen, C. L., Owens, M., Grace, M., Huh, K. (2004). Mechanisms of Human Papillomavirus-Induced Oncogenesis. J. Virol. 78: 11451-11460 [Full Text]  
  • Hoti, N., Zhu, D.-e, Song, Z., Wu, Z., Tabassum, S., Wu, M. (2004). p53-Dependent Apoptotic Mechanism of a New Designer Bimetallic Compound Tri-phenyl Tin Benzimidazolethiol Copper Chloride (TPT-CuCl2): In Vivo Studies in Wistar Rats as Well as in Vitro Studies in Human Cervical Cancer Cells. J. Pharmacol. Exp. Ther. 311: 22-33 [Abstract] [Full Text]  
  • Engelmark, M., Beskow, A., Magnusson, J., Erlich, H., Gyllensten, U. (2004). Affected sib-pair analysis of the contribution of HLA class I and class II loci to development of cervical cancer. Hum Mol Genet 13: 1951-1958 [Abstract] [Full Text]  
  • Ha, P. K., Califano, J. A. (2004). THE ROLE OF HUMAN PAPILLOMAVIRUS IN ORAL CARCINOGENESIS. CROBM 15: 188-196 [Abstract] [Full Text]  
  • Longworth, M. S., Laimins, L. A. (2004). Pathogenesis of Human Papillomaviruses in Differentiating Epithelia. Microbiol. Mol. Biol. Rev. 68: 362-372 [Abstract] [Full Text]  
  • McMurray, H. R., McCance, D. J. (2004). Degradation of p53, Not Telomerase Activation, by E6 Is Required for Bypass of Crisis and Immortalization by Human Papillomavirus Type 16 E6/E7. J. Virol. 78: 5698-5706 [Abstract] [Full Text]  
  • Warrino, D. E., Olson, W. C., Knapp, W. T., Scarrow, M. I., D'Ambrosio-Brennan, L. J., Guido, R. S., Edwards, R. P., Kast, W. M., Storkus, W. J. (2004). Disease-Stage Variance in Functional CD4+ T-Cell Responses Against Novel Pan-Human Leukocyte Antigen-D Region Presented Human Papillomavirus-16 E7 Epitopes. Clin. Cancer Res. 10: 3301-3308 [Abstract] [Full Text]  
  • Helfrich, I., Chen, M., Schmidt, R., Furstenberger, G., Kopp-Schneider, A., Trick, D., Grone, H.-J., zur Hausen, H., Rosl, F. (2004). Increased Incidence of Squamous Cell Carcinomas in Mastomys natalensis Papillomavirus E6 Transgenic Mice during Two-Stage Skin Carcinogenesis. J. Virol. 78: 4797-4805 [Abstract] [Full Text]  
  • Cooray, S. (2004). The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J. Gen. Virol. 85: 1065-1076 [Abstract] [Full Text]  
  • Longworth, M. S., Laimins, L. A. (2004). The Binding of Histone Deacetylases and the Integrity of Zinc Finger-Like Motifs of the E7 Protein Are Essential for the Life Cycle of Human Papillomavirus Type 31. J. Virol. 78: 3533-3541 [Abstract] [Full Text]  
  • Patel, D., Incassati, A., Wang, N., McCance, D. J. (2004). Human Papillomavirus Type 16 E6 and E7 Cause Polyploidy in Human Keratinocytes and Up-Regulation of G2-M-Phase Proteins. Cancer Res. 64: 1299-1306 [Abstract] [Full Text]  
  • Balsitis, S. J., Sage, J., Duensing, S., Munger, K., Jacks, T., Lambert, P. F. (2003). Recapitulation of the Effects of the Human Papillomavirus Type 16 E7 Oncogene on Mouse Epithelium by Somatic Rb Deletion and Detection of pRb-Independent Effects of E7 In Vivo. Mol. Cell. Biol. 23: 9094-9103 [Abstract] [Full Text]  
  • Tao, M., Kruhlak, M., Xia, S., Androphy, E., Zheng, Z.-M. (2003). Signals That Dictate Nuclear Localization of Human Papillomavirus Type 16 Oncoprotein E6 in Living Cells. J. Virol. 77: 13232-13247 [Abstract] [Full Text]  
  • Watson, R. A., Thomas, M., Banks, L., Roberts, S. (2003). Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes. J. Cell Sci. 116: 4925-4934 [Abstract] [Full Text]  
  • Duensing, S., Munger, K. (2003). Human Papillomavirus Type 16 E7 Oncoprotein Can Induce Abnormal Centrosome Duplication through a Mechanism Independent of Inactivation of Retinoblastoma Protein Family Members. J. Virol. 77: 12331-12335 [Abstract] [Full Text]  
  • Fu, B., Quintero, J., Baker, C. C. (2003). Keratinocyte Growth Conditions Modulate Telomerase Expression, Senescence, and Immortalization by Human Papillomavirus Type 16 E6 and E7 Oncogenes. Cancer Res. 63: 7815-7824 [Abstract] [Full Text]  
  • Schreurs, M. W. J., Scholten, K. B. J., Kueter, E. W. M., Ruizendaal, J. J., Meijer, C. J. L. M., Hooijberg, E. (2003). In Vitro Generation and Life Span Extension of Human Papillomavirus Type 16-Specific, Healthy Donor-Derived CTL Clones. J. Immunol. 171: 2912-2921 [Abstract] [Full Text]  
  • Riley, R. R., Duensing, S., Brake, T., Munger, K., Lambert, P. F., Arbeit, J. M. (2003). Dissection of Human Papillomavirus E6 and E7 Function in Transgenic Mouse Models of Cervical Carcinogenesis. Cancer Res. 63: 4862-4871 [Abstract] [Full Text]  
  • Veldman, T., Liu, X., Yuan, H., Schlegel, R. (2003). Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc. Natl. Acad. Sci. USA 100: 8211-8216 [Abstract] [Full Text]  
  • Gallo, G, Bibbo, M, Bagella, L, Zamparelli, A, Sanseverino, F, Giovagnoli, M R, Vecchione, A, Giordano, A (2003). Study of viral integration of HPV-16 in young patients with LSIL. J. Clin. Pathol. 56: 532-536 [Abstract] [Full Text]  
  • Acs, G., Zhang, P. J., McGrath, C. M., Acs, P., McBroom, J., Mohyeldin, A., Liu, S., Lu, H., Verma, A. (2003). Hypoxia-Inducible Erythropoietin Signaling in Squamous Dysplasia and Squamous Cell Carcinoma of the Uterine Cervix and Its Potential Role in Cervical Carcinogenesis and Tumor Progression. Am. J. Pathol. 162: 1789-1806 [Abstract] [Full Text]  
  • Hall, A. H. S., Alexander, K. A. (2003). RNA Interference of Human Papillomavirus Type 18 E6 and E7 Induces Senescence in HeLa Cells. J. Virol. 77: 6066-6069 [Abstract] [Full Text]  
  • Cid-Arregui, A., Juarez, V., Hausen, H. z. (2003). A Synthetic E7 Gene of Human Papillomavirus Type 16 That Yields Enhanced Expression of the Protein in Mammalian Cells and Is Useful for DNA Immunization Studies. J. Virol. 77: 4928-4937 [Abstract] [Full Text]  
  • Genther, S. M., Sterling, S., Duensing, S., Munger, K., Sattler, C., Lambert, P. F. (2003). Quantitative Role of the Human Papillomavirus Type 16 E5 Gene during the Productive Stage of the Viral Life Cycle. J. Virol. 77: 2832-2842 [Abstract] [Full Text]  
  • Schaal, T. D., Mallet, W. G., McMinn, D. L., Nguyen, N. V., Sopko, M. M., John, S., Parekh, B. S. (2003). Inhibition of human papilloma virus E2 DNA binding protein by covalently linked polyamides. Nucleic Acids Res 31: 1282-1291 [Abstract] [Full Text]  
  • Mukai, H. (2003). The Structure and Function of PKN, a Protein Kinase Having a Catalytic Domain Homologous to That of PKC. J Biochem 133: 17-27 [Abstract] [Full Text]  
  • Singh, L., Gao, Q., Kumar, A., Gotoh, T., Wazer, D. E., Band, H., Feig, L. A., Band, V. (2002). The High-Risk Human Papillomavirus Type 16 E6 Counters the GAP Function of E6TP1 toward Small Rap G Proteins. J. Virol. 77: 1614-1620 [Abstract] [Full Text]  
  • Kaufmann, A. M., Stern, P. L., Rankin, E. M., Sommer, H., Nuessler, V., Schneider, A., Adams, M., Onon, T. S., Bauknecht, T., Wagner, U., Kroon, K., Hickling, J., Boswell, C. M., Stacey, S. N., Kitchener, H. C., Gillard, J., Wanders, J., Roberts, J. St. C., Zwierzina, H. (2002). Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18 E6 and E7 Genes, in Women with Progressive Cervical Cancer. Clin. Cancer Res. 8: 3676-3685 [Abstract] [Full Text]  
  • Zeng, M., Kumar, A., Meng, G., Gao, Q., Dimri, G., Wazer, D., Band, H., Band, V. (2002). Human Papilloma Virus 16 E6 Oncoprotein Inhibits Retinoic X Receptor-mediated Transactivation by Targeting Human ADA3 Coactivator. J. Biol. Chem. 277: 45611-45618 [Abstract] [Full Text]  
  • Nguyen, M., Song, S., Liem, A., Androphy, E., Liu, Y., Lambert, P. F. (2002). A Mutant of Human Papillomavirus Type 16 E6 Deficient in Binding {alpha}-Helix Partners Displays Reduced Oncogenic Potential In Vivo. J. Virol. 76: 13039-13048 [Abstract] [Full Text]  
  • You, H., Liu, Y., Carey, M. J., Lowery, C. L., Hermonat, P. L. (2002). Defective 3A Trophoblast-Endometrial Cell Adhesion and Altered 3A Growth and Survival by Human Papillomavirus Type 16 Oncogenes. Mol Cancer Res 1: 25-31 [Abstract] [Full Text]  
  • Yuan, H., Veldman, T., Rundell, K., Schlegel, R. (2002). Simian Virus 40 Small Tumor Antigen Activates AKT and Telomerase and Induces Anchorage-Independent Growth of Human Epithelial Cells. J. Virol. 76: 10685-10691 [Abstract] [Full Text]  
  • Nakahara, T., Nishimura, A., Tanaka, M., Ueno, T., Ishimoto, A., Sakai, H. (2002). Modulation of the Cell Division Cycle by Human Papillomavirus Type 18 E4. J. Virol. 76: 10914-10920 [Abstract] [Full Text]  
  • Kumar, A., Zhao, Y., Meng, G., Zeng, M., Srinivasan, S., Delmolino, L. M., Gao, Q., Dimri, G., Weber, G. F., Wazer, D. E., Band, H., Band, V. (2002). Human Papillomavirus Oncoprotein E6 Inactivates the Transcriptional Coactivator Human ADA3. Mol. Cell. Biol. 22: 5801-5812 [Abstract] [Full Text]  
  • Berger, A. J., Baege, A., Guillemette, T., Deeds, J., Meyer, R., Disbrow, G., Schlegel, R., Schlegel, R. (2002). Insulin-Like Growth Factor-Binding Protein 3 Expression Increases during Immortalization of Cervical Keratinocytes by Human Papillomavirus Type 16 E6 and E7 Proteins. Am. J. Pathol. 161: 603-610 [Abstract] [Full Text]  
  • Gao, Q., Kumar, A., Singh, L., Huibregtse, J. M., Beaudenon, S., Srinivasan, S., Wazer, D. E., Band, H., Band, V. (2002). Human Papillomavirus E6-induced Degradation of E6TP1 Is Mediated by E6AP Ubiquitin Ligase. Cancer Res. 62: 3315-3321 [Abstract] [Full Text]  
  • Baege, A. C., Berger, A., Schlegel, R., Veldman, T., Schlegel, R. (2002). Cervical Epithelial Cells Transduced with the Papillomavirus E6/E7 Oncogenes Maintain Stable Levels of Oncoprotein Expression but Exhibit Progressive, Major Increases in hTERT Gene Expression and Telomerase Activity. Am. J. Pathol. 160: 1251-1257 [Abstract] [Full Text]  
  • Levine, A. M. (2002). Evaluation and Management of HIV-Infected Women. ANN INTERN MED 136: 228-242 [Abstract] [Full Text]  
  • Zhang, B., Spandau, D. F., Roman, A. (2002). E5 Protein of Human Papillomavirus Type 16 Protects Human Foreskin Keratinocytes from UV B-Irradiation-Induced Apoptosis. J. Virol. 76: 220-231 [Abstract] [Full Text]  
  • Degenhardt, Y. Y., Silverstein, S. (2001). Interaction of Zyxin, a Focal Adhesion Protein, with the E6 Protein from Human Papillomavirus Type 6 Results in Its Nuclear Translocation. J. Virol. 75: 11791-11802 [Abstract] [Full Text]  
  • Velders, M. P., McElhiney, S., Cassetti, M. C., Eiben, G. L., Higgins, T., Kovacs, G. R., Elmishad, A. G., Kast, W. M., Smith, L. R. (2001). Eradication of Established Tumors by Vaccination with Venezuelan Equine Encephalitis Virus Replicon Particles Delivering Human Papillomavirus 16 E7 RNA. Cancer Res. 61: 7861-7867 [Abstract] [Full Text]  
  • Helt, A.-M., Galloway, D. A. (2001). Destabilization of the Retinoblastoma Tumor Suppressor by Human Papillomavirus Type 16 E7 Is Not Sufficient To Overcome Cell Cycle Arrest in Human Keratinocytes. J. Virol. 75: 6737-6747 [Abstract] [Full Text]  
  • Caceres-Cortes, J. R., Alvarado-Moreno, J. A., Waga, K., Rangel-Corona, R., Monroy-Garcia, A., Rocha-Zavaleta, L., Urdiales-Ramos, J., Weiss-Steider, B., Haman, A., Hugo, P., Brousseau, R., Hoang, T. (2001). Implication of Tyrosine Kinase Receptor and Steel Factor in Cell Density-dependent Growth in Cervical Cancers and Leukemias. Cancer Res. 61: 6281-6289 [Abstract] [Full Text]  
  • Oh, S. T., Kyo, S., Laimins, L. A. (2001). Telomerase Activation by Human Papillomavirus Type 16 E6 Protein: Induction of Human Telomerase Reverse Transcriptase Expression through Myc and GC-Rich Sp1 Binding Sites. J. Virol. 75: 5559-5566 [Abstract] [Full Text]  
  • Nees, M., Geoghegan, J. M., Hyman, T., Frank, S., Miller, L., Woodworth, C. D. (2001). Papillomavirus Type 16 Oncogenes Downregulate Expression of Interferon-Responsive Genes and Upregulate Proliferation-Associated and NF-{kappa}B-Responsive Genes in Cervical Keratinocytes. J. Virol. 75: 4283-4296 [Abstract] [Full Text]  
  • Gao, Q., Singh, L., Kumar, A., Srinivasan, S., Wazer, D. E., Band, V. (2001). Human Papillomavirus Type 16 E6-Induced Degradation of E6TP1 Correlates with Its Ability To Immortalize Human Mammary Epithelial Cells. J. Virol. 75: 4459-4466 [Abstract] [Full Text]  
  • Veldman, T., Horikawa, I., Barrett, J. C., Schlegel, R. (2001). Transcriptional Activation of the Telomerase hTERT Gene by Human Papillomavirus Type 16 E6 Oncoprotein. J. Virol. 75: 4467-4472 [Abstract] [Full Text]  
  • Velders, M. P., Weijzen, S., Eiben, G. L., Elmishad, A. G., Kloetzel, P.-M., Higgins, T., Ciccarelli, R. B., Evans, M., Man, S., Smith, L., Kast, W. M. (2001). Defined Flanking Spacers and Enhanced Proteolysis Is Essential for Eradication of Established Tumors by an Epitope String DNA Vaccine. J. Immunol. 166: 5366-5373 [Abstract] [Full Text]  
  • Degenhardt, Y. Y., Silverstein, S. J. (2001). Gps2, a Protein Partner for Human Papillomavirus E6 Proteins. J. Virol. 75: 151-160 [Abstract] [Full Text]  
  • Nagele, R., Velasco, A., Anderson, W., McMahon, D., Thomson, Z, Fazekas, J, Wind, K, Lee, H (2001). Telomere associations in interphase nuclei: possible role in maintenance of interphase chromosome topology. J. Cell Sci. 114: 377-388 [Abstract]  
  • Nakagawa, S., Huibregtse, J. M. (2000). Human Scribble (Vartul) Is Targeted for Ubiquitin-Mediated Degradation by the High-Risk Papillomavirus E6 Proteins and the E6AP Ubiquitin-Protein Ligase. Mol. Cell. Biol. 20: 8244-8253 [Abstract] [Full Text]  
  • Han, R., Cladel, N. M., Reed, C. A., Peng, X., Budgeon, L. R., Pickel, M., Christensen, N. D. (2000). DNA Vaccination Prevents and/or Delays Carcinoma Development of Papillomavirus-Induced Skin Papillomas on Rabbits. J. Virol. 74: 9712-9716 [Abstract] [Full Text]  
  • Escalante-Alcalde, D., Recillas-Targa, F., Valencia, C., Santa-Olalla, J., Chávez, P., Marroquín, A., Gutiérrez-X, L., Gariglio, P., Covarrubias, L. (2000). Expression of E6 and E7 Papillomavirus Oncogenes in the Outer Root Sheath of Hair Follicles Extends the Growth Phase and Bypasses Resting at Telogen. Cell Growth Differ. 11: 527-539 [Abstract] [Full Text]  
  • Goodwin, E. C., Yang, E., Lee, C.-J., Lee, H.-W., DiMaio, D., Hwang, E.-S. (2000). Rapid induction of senescence in human cervical carcinoma cells. Proc. Natl. Acad. Sci. USA 97: 10978-10983 [Abstract] [Full Text]  
  • Mannhardt, B., Weinzimer, S. A., Wagner, M., Fiedler, M., Cohen, P., Jansen-Dürr, P., Zwerschke, W. (2000). Human Papillomavirus Type 16 E7 Oncoprotein Binds and Inactivates Growth-Inhibitory Insulin-Like Growth Factor Binding Protein 3. Mol. Cell. Biol. 20: 6483-6495 [Abstract] [Full Text]  
  • Muderspach, L., Wilczynski, S., Roman, L., Bade, L., Felix, J., Small, L. A., Kast, W. M., Fascio, G., Marty, V., Weber, J. (2000). A Phase I Trial of a Human Papillomavirus (HPV) Peptide Vaccine for Women with High-Grade Cervical and Vulvar Intraepithelial Neoplasia Who Are HPV 16 Positive. Clin. Cancer Res. 6: 3406-3416 [Abstract] [Full Text]  
  • Kämmer, C., Warthorst, U., Torrez-Martinez, N., Wheeler, C. M., Pfister, H. (2000). Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J. Gen. Virol. 81: 1975-1981 [Abstract] [Full Text]  
  • Zhu, J., Chen, X. (2000). MCG10, a Novel p53 Target Gene That Encodes a KH Domain RNA-Binding Protein, Is Capable of Inducing Apoptosis and Cell Cycle Arrest in G2-M. Mol. Cell. Biol. 20: 5602-5618 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»